all - Opinion Summaries

US ex rel Campie v. Gilead Sciences, Inc.

White Collar Crime, Labor & Employment Law, Consumer Protection Law, Drugs & Biotech
Reversing the district court's dismissal of claims under the False Claims Act by realtors against their former employer who made false statements...

Oregon Prescription Drug Monitoring Program v. USDEA

Constitutional Law, Drugs & Biotech, Civil Procedure
Reversing the district court order that the United States Drug Enforcement Administration's use of administrative subpeonas issued against Oregon's...

Storer v. Clark

Drugs & Biotech, Intellectual Property, Patent
In a patent interference case relating to a treatment for hepatitis C, the district court's judgment is affirmed where the appellant's provisional...

Bristol-Myers Squibb Co. v. Superior Court of Cal., San Francisco Cty.

Civil Procedure, Drugs & Biotech
In a suit brought by plaintiffs, most of whom are not California residents, against Bristol-Myers Squibb Company (BMS) in California state court,...

Sandoz Inc. v. Amgen Inc.

Intellectual Property, Patent, Drugs & Biotech
In a patent infringement suit involving filgrastim drugs, arising in the context of the Biologics Price Competition and Innovation Act of 2009...

In Re: Zoloft Products Liability Litigation

Class Actions, Evidence, Drugs & Biotech
In multi-district litigation involving allegations that the anti-depressant drug Zoloft, manufactured by Pfizer, causes cardiac birth defects when...

Mylan Institutional LLC v. Aurobindo Pharma Ltd.

Intellectual Property, Patent, Drugs & Biotech
In an infringement action involving patents which relate to isosulfan blue (ISB), a triarylmethane dye used to map lymph nodes, the district court's...

Amphastar Pharms., Inc. v. Aventis Pharms., Inc.

Intellectual Property, Patent, Injury & Tort Law, Drugs & Biotech, Attorney's Fees
In a qui tam suit under the False Claims Act alleging that defendant committed fraud against the U.S. Patent and Trademark Office (PTO) and obtained...

Helsinn Healthcare S.A. v. Teva Pharms. USA, Inc.

Intellectual Property, Patent, Drugs & Biotech
In a suit involving patents directed to intravenous formulations of palonosetron for reducing or reducing the likelihood of chemotherapy-induced...

In re: Lipitor Antitrust Litig.

Civil Procedure, Intellectual Property, Patent, Drugs & Biotech
In consolidated appeals involve allegations that defendant companies holding the patents for Lipitor and Effexor XR delayed entry into the market of...